Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Regenerative Medicine: The Next Frontier for Big Pharma
Nov 17, 2008 12:19 PM
- BioMimetic Gets FDA Confirmation Of GEM OS1 Study Status
Apr 21, 2008 06:46 PM
- BioMimetic Gets FDA Confirmation Of GEM OS1 Study Status
Apr 21, 2008 06:46 PM
- BioMimetic Therapeutics: Deutsche Bank Reiterates Buy
Apr 03, 2008 10:50 AM
- NASDAQ Technical Picture - Profit Taking after the Surge
Mar 13, 2008 02:22 AM
- Earnings Summary: Wednesday, March 12, 2008
Mar 13, 2008 02:18 AM
- Stagflation
Dec 14, 2007 10:23 AM
- LATE TRADING: Aetna Up After Reaffirming Operating EPS Outlook
Sep 18, 2006 05:09 PM
- LATE TRADING: Aetna Up After Reaffirming Operating EPS Outlook
Sep 18, 2006 05:09 PM
- LATE TRADING: Aetna Up After Reaffirming Operating EPS Outlook
Sep 18, 2006 05:09 PM
- BioMimetic Therapeutics, Inc. Announces Patent Allowance from United States Patent and Trademark Office for PDGF Compositions Patent
Nov 21, 2008 08:31 AM
- BioMimetic Therapeutics Ranked 181st Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500
Nov 13, 2008 04:27 PM
- BioMimetic Therapeutics Reports 2008 Third Quarter Results
Nov 10, 2008 04:03 PM
- BioMimetic Therapeutics to Report 2008 Third Quarter Financial Results on November 10
Nov 06, 2008 11:08 AM
- BioMimetic Therapeutics Reports Promising Clinical Results Using Augment Injectable Bone Graft to Treat Distal Radius Fractures
Oct 29, 2008 08:40 AM
- BioMimetic Therapeutics Adds $39 Million of Liquidity
Oct 27, 2008 04:59 PM
- BioMimetic Therapeutics Announces No Changes Requested by Independent Data Monitoring Committee to Pivotal Trial Design for Augment(TM) Bone Graft
Sep 23, 2008 04:32 PM
- BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the UBS Global Life Sciences Conference
Sep 22, 2008 10:30 AM
- BioMimetic Therapeutics Reports 2008 Second Quarter Results
Aug 11, 2008 04:20 PM
- BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the Canaccord Adams Global Growth Conference
Aug 08, 2008 10:02 AM
- Form 4 BIOMIMETIC THERAPEUTICS, For: Nov 11 Filed by: Novo A/S (10K)
Nov 13, 2008 07:17 AM
- Form 4 BIOMIMETIC THERAPEUTICS, For: Oct 27 Filed by: Friedlaender Gary E (10K)
Oct 29, 2008 05:17 PM
- Form 4 BIOMIMETIC THERAPEUTICS, For: Oct 27 Filed by: Lynch Samuel Eugene (10K)
Oct 29, 2008 05:14 PM
- Form 4 BIOMIMETIC THERAPEUTICS, For: Sep 08 Filed by: Novo A/S (10K)
Sep 10, 2008 02:41 PM
- Form 4 BIOMIMETIC THERAPEUTICS, For: Sep 05 Filed by: Novo A/S (10K)
Sep 09, 2008 04:04 PM
- Form 4 BIOMIMETIC THERAPEUTICS, For: Sep 03 Filed by: Novo A/S (10K)
Sep 05, 2008 06:24 PM
- Form 4 BIOMIMETIC THERAPEUTICS, For: Sep 04 Filed by: Novo A/S (10K)
Sep 05, 2008 06:23 PM
- Form 4 BIOMIMETIC THERAPEUTICS, For: Sep 02 Filed by: Novo A/S (10K)
Sep 03, 2008 06:22 PM
- Form 4 BIOMIMETIC THERAPEUTICS, For: Aug 29 Filed by: Novo A/S (10K)
Sep 03, 2008 06:22 PM
- Form 4 BIOMIMETIC THERAPEUTICS, For: Aug 27 Filed by: Novo A/S (10K)
Aug 29, 2008 02:12 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
BMTI
|
Compare to S&P
|
| YTD |
-50.49 %
|
-18.88 %
|
| 4 Weeks |
5.13 %
|
13.64 %
|
| 12 Weeks |
-16.50 %
|
15.74 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 16.00 %
|
|
EPS Growth in Last Year: -35.48 %
|
|
Sales Growth in Last Quarter: -8.52 %
|
|
Sales Growth in Last Quarter: -74.83 %
|
|
|
